Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 34 articles: HTML format

Single Articles

April 2024
1. VASAVADA A, Stankiewicz Karita HC, Lin J, Schouten J, et al
   Methylation markers for anal cancer screening: A repeated cross-sectional analysis of people living with HIV, 2015-2016.
   Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34977.
   PubMed     Abstract available
   
   
   
2. DOWNHAM L, Rol ML, Forestier M, Romero P, et al
   Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
   Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953.
   PubMed     Abstract available
   
   
   
3. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
   Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
   Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
   PubMed     Abstract available
   
   
   January 2024
4. STIER EA, Clarke MA, Deshmukh AA, Wentzensen N, et al
   International Anal Neoplasia Society's consensus guidelines for anal cancer screening.
   Int J Cancer. 2024 Jan 31. doi: 10.1002/ijc.34850.
   PubMed     Abstract available
   
   
   November 2023
5. TULSIDAS S, Fontes F, Monteiro K, Mussa M, et al
   Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016-2018.
   Int J Cancer. 2023 Nov 14. doi: 10.1002/ijc.34779.
   PubMed     Abstract available
   
   
   
6. BONI SP, Tenet V, Horo A, Heideman DAM, et al
   High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Cote d'Ivoire, 2018 to 2020.
   Int J Cancer. 2023 Nov 9. doi: 10.1002/ijc.34774.
   PubMed     Abstract available
   
   
   September 2023
7. LIU Y, Bhardwaj S, Sigel K, Winters J, et al
   Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV.
   Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34734.
   PubMed     Abstract available
   
   
   
8. MUNGO C, Osongo CO, Ambaka J, Omoto J, et al
   Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
   Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34737.
   PubMed     Abstract available
   
   
   
9. ENGELS EA, Shiels MS, Barnabas RV, Bohlius J, et al
   State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI.
   Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34727.
   PubMed     Abstract available
   
   
   
10. DHOKOTERA TG, Muchengeti M, Davidovic M, Rohner E, et al
    Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study.
    Int J Cancer. 2023 Sep 8. doi: 10.1002/ijc.34712.
    PubMed     Abstract available
    
    
    
11. FERNANDEZ VILLALOBOS NV, Ruffieux Y, Haas AD, Chinogurei C, et al
    Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
    Int J Cancer. 2023 Sep 2. doi: 10.1002/ijc.34707.
    PubMed     Abstract available
    
    
    August 2023
12. MOORAD R, Kasonkanji E, Gumulira J, Gondwe Y, et al
    A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
    Int J Cancer. 2023 Aug 21. doi: 10.1002/ijc.34689.
    PubMed     Abstract available
    
    
    
13. HUANG J, Chan SC, Fung YC, Pang WS, et al
    Global incidence, risk factors and trends of vulvar cancer: A country-based analysis of cancer registries.
    Int J Cancer. 2023 Aug 2. doi: 10.1002/ijc.34655.
    PubMed     Abstract available
    
    
    July 2023
14. DIAS GONCALVES LIMA F, Schim van der Loeff M
    Comments on: "A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups".
    Int J Cancer. 2023 Jul 4. doi: 10.1002/ijc.34641.
    PubMed    
    
    
    June 2023
15. MBURU W, Devesa SS, Check D, Shiels MS, et al
    Incidence of Burkitt lymphoma in the United States during 2000 to 2019.
    Int J Cancer. 2023 Jun 6. doi: 10.1002/ijc.34618.
    PubMed     Abstract available
    
    
    May 2023
16. HOSSEINI B, Zendehdel K, Bouaoun L, Hall AL, et al
    Bladder cancer risk in relation to occupations held in a nationwide case-control study in Iran.
    Int J Cancer. 2023 May 9. doi: 10.1002/ijc.34560.
    PubMed     Abstract available
    
    
    
17. NYITRAY AG, Nitkowski J, McAuliffe TL, Brzezinski B, et al
    Home-based self-sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self-Swab Study.
    Int J Cancer. 2023 May 9. doi: 10.1002/ijc.34553.
    PubMed     Abstract available
    
    
    March 2023
18. ALBUQUERQUE A
    Comments on "Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis": Prevention of anal squamous cell carcinoma in women: How to move forward: Prevention of anal squamous c
    Int J Cancer. 2023 Mar 8. doi: 10.1002/ijc.34490.
    PubMed    
    
    
    February 2023
19. MOTLHALE M, Muchengeti M, Bradshaw D, Chen WC, et al
    Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
    Int J Cancer. 2023 Feb 2. doi: 10.1002/ijc.34454.
    PubMed     Abstract available
    
    
    December 2022
20. BOUCHERON P, Anele A, Offiah AU, Zietsman A, et al
    Reproductive history and breast cancer survival: findings from the African Breast Cancer - Disparities in Outcomes cohort and implications of Africa's fertility transition on breast cancer prognosis.
    Int J Cancer. 2022 Dec 22. doi: 10.1002/ijc.34411.
    PubMed     Abstract available
    
    
    November 2022
21. BAENA A, Mesher D, Salgado Y, Martinez S, et al
    Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study.
    Int J Cancer. 2022 Nov 30. doi: 10.1002/ijc.34384.
    PubMed     Abstract available
    
    
    October 2022
22. RAKISLOVA N, Carreras-Dieguez N, Manzotti C, Saude O, et al
    Differential etiopathogenic features of vulvar squamous cell carcinomas in sub-Saharan Africa and Europe.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34314.
    PubMed     Abstract available
    
    
    September 2022
23. KAHESA C, Thomsen LT, Linde DS, Mchome B, et al
    Comparison of human papillomavirus (HPV)-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Int J Cancer. 2022 Sep 12. doi: 10.1002/ijc.34283.
    PubMed     Abstract available
    
    
    August 2022
24. DESHMUKH AA, Damgacioglu H, Georges D, Sonawane K, et al
    Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: a worldwide analysis.
    Int J Cancer. 2022 Aug 28. doi: 10.1002/ijc.34269.
    PubMed     Abstract available
    
    
    
25. RASHIDIAN H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, et al
    Opium use and risk of lung cancer: A multicenter case-control study in Iran.
    Int J Cancer. 2022 Aug 13. doi: 10.1002/ijc.34244.
    PubMed     Abstract available
    
    
    
26. SENGAYI-MUCHENGETI M, Singh E, Chen WC, Bradshaw D, et al
    Thirteen cancers associated with HIV infection in a Black South African cancer patient population (1995-2016).
    Int J Cancer. 2022 Aug 4. doi: 10.1002/ijc.34236.
    PubMed     Abstract available
    
    
    July 2022
27. JOSHI S, Muwonge R, Kulkarni V, Mandolkar M, et al
    Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India.
    Int J Cancer. 2022 Jul 19. doi: 10.1002/ijc.34221.
    PubMed     Abstract available
    
    
    
28. CLARKE MA, Deshmukh AA, Suk R, Roberts J, et al
    A Systematic Review and Meta-Analysis of Cytology and HPV-related Biomarkers for Anal Cancer Screening Among Different Risk Groups.
    Int J Cancer. 2022 Jul 6. doi: 10.1002/ijc.34199.
    PubMed     Abstract available
    
    
    June 2022
29. MOLEBATSI K, Iyer HS, Kohler RE, Gabegwe K, et al
    Improving identification of symptomatic cancer at primary care clinics: A predictive modeling analysis in Botswana.
    Int J Cancer. 2022 Jun 18. doi: 10.1002/ijc.34178.
    PubMed     Abstract available
    
    
    
30. FABER MT, Frederiksen K, Palefsky JM, Kjaer SK, et al
    A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer.
    Int J Cancer. 2022 Jun 3. doi: 10.1002/ijc.34143.
    PubMed     Abstract available
    
    
    February 2022
31. AYENI OA, O'Neil DS, Pumpalova YS, Chen WC, et al
    Impact of HIV infection on Survival among Women with Stage I-III Breast Cancer: Results from the South African Breast Cancer and HIV Outcomes Study.
    Int J Cancer. 2022 Feb 26. doi: 10.1002/ijc.33981.
    PubMed     Abstract available
    
    
    January 2022
32. IBRAHIM KHALIL A, Franceschi S, de Martel C, Bray F, et al
    Burden of Kaposi sarcoma according to HIV status: a systematic review and global analysis.
    Int J Cancer. 2022 Jan 27. doi: 10.1002/ijc.33951.
    PubMed     Abstract available
    
    
    October 2021
33. IBRAHIM KHALIL A, Mpunga T, Wei F, Baussano I, et al
    Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33841.
    PubMed     Abstract available
    
    
    
34. MPUNGA T, Clifford GM, Morgan EA, Milner DA Jr, et al
    Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012-2018.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33840.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.